DMDmitry Mikhailivich Monakov

Dmitry Mikhailivich Monakov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Dmitry Mikhailivich Monakov has a total of 114 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The molecular genetic landscape of prostate cancer and its association with thrombosis

    by Попов Анатолий Юрьевич, Anatoly Yu. Popov, Монаков Дмитрий Михайлович, Dmitry M. Monakov, Байтман Татьяна Павловна, Tatiana P. Baitman, Симонов Антон Дмитриевич, Anton D. Simonov, Борукаев Андемиркан Юриевич, Andemirkan Yu. Borukaev, et al.

    Prostate cancer (PCa) remains one of the leading causes of cancer morbidity and mortality in men. In recent years, significant progress has been made in understanding the molecular genetic heterogeneity of PCa, which determines the aggressiveness of the disease, prognosis, and response to therapy. In parallel, evidence is accumulating that the oncological process and its treatment, especially androgen deprivation therapy, are accompanied by an increased risk of venous thromboembolism (VTE). This review examines the association between the PCa molecular landscape and thrombotic complications. We analyzed publications in PubMed, Scopus, Web of Science, and ResearchGate, mainly for 2010–2025. The general mechanisms of the cancer–thrombosis link were considered, including expression of tissue factor, cancer procoagulant, pro-inflammatory cytokines, platelet activation, neutrophil extracellular traps, and suppression of fibrinolysis. The key molecular genetic subtypes of PCa are described in detail: defects in homologous recombination repair genes (BRCA1/2, ATM, CHEK2, PALB2), TMPRSS2-ERG fusion, PTEN deletion, TP53 mutations, and androgen receptor amplification. Aggressive tumor subtypes have been shown to be indirectly associated with a higher risk of VTE through rapid progression, metastasis, intensive treatment, and deterioration of the patient’s general condition. The contribution of androgen deprivation therapy to hypercoagulation is discussed. Interdisciplinary clinical guidelines and an algorithm of actions for geneticists, oncologists, chemotherapists, vascular surgeons, and anesthesiologists and critical care physicians are presented. Particular attention is paid to practical aspects: VTE risk stratification, choice of anticoagulant prophylaxis, and perioperative management. The role of molecular profiling in identifying patients at high thrombotic risk is emphasized. Unresolved problems are identified: the lack of direct biomarkers of tumor thrombogenicity, the need for integrated VTE risk scales taking into account genomic data, and issues of personalization of thromboprophylaxis. It is concluded that a personalized multidisciplinary approach combining PCa molecular profiling, thrombotic risk assessment, and timely VTE prevention is needed.

  • Open Access

    The role of arterial hypertension and antihypertensive therapy in planning nerve-sparing prostatectomy: impact on erectile function

    by A. Yu. Borukaev, T. P. Baitman, L. T. Savin, M. A. Yurlova, N. Yu. Ardashova, D. M. Monakov, А. Ю. Борукаев, Т. П. Байтман, Л. Т. Савин, М. А. Юрлова, et al.

    Assessment of erectile function in patients with prostate cancer is essential when planning nerve-sparing radical prostatectomy. However, reliance solely on validated questionnaires may result in biased estimates because of the subjective nature of self-assessment and the psychological impact of a cancer diagnosis. Therefore, comparing questionnairebased findings with objective methods of erectile function assessment and evaluating factors that may influence erectile function, including arterial hypertension and antihypertensive therapy, is clinically important. Purpose of the study . To evaluate preoperative erectile function in patients with low- and intermediate-risk prostate cancer scheduled for robot-assisted nerve-sparing radical prostatectomy and to assess the impact of hypertension, hypertension grade, and antihypertensive therapy on erectile function. Patients and methods . This prospective study included 150 patients with prostate cancer. Erectile function was assessed using the International Index of Erectile Function‑5 (IIEF‑5), the Erection Hardness Score (EHS), the Sexual Encounter Profile (SEP), and nocturnal penile tumescence (NPT) monitoring with the Androscan MIT device. Statistical analysis was performed using StatTech version 4.13.0. Results . The presence of hypertension was significantly associated with a greater severity of erectile dysfunction (ED), as assessed both by IIEF‑5 (p = 0.030) and NPT data (p = 0.023). The stage of hypertension and the grade of arterial hypertension were associated with deterioration of objective NPT parameters (p = 0.047 and p = 0.031, respectively). Among antihypertensive medications, the use of ACE inhibitors/angiotensin receptor blockers (ARBs), calcium channel blockers, and diuretics (predominantly indapamide) was associated with a significant reduction in NPT duration; statins, classified separately as lipid-lowering rather than antihypertensive therapy, showed no significant association. ED severity categories assigned by IIEF‑5 and by Androscan did not match in 62.2 % of cases. Conclusion . Arterial hypertension is an independent preoperative risk factor for erectile dysfunction in patients with prostate cancer. Objective NPT monitoring identifies a substantially higher prevalence of erectile function impairment compared with self-assessment using the IIEF‑5. These findings may be useful in selecting candidates for nerve-sparing prostatectomy.

  • Open Access

    Thrombosis and prostate cancer: a modern perspective of epidemiology, pathogenesis, prognosis, and preventive strategies

    by Anatoly Yu. Popov, Dmitry M. Monakov, Tatiana P. Baitman, Nikolay V. Zhukov, Anton D. Simonov, Leonid T. Savin, Vladislav A. Makarov, Alexander A. Gritskevich

    Thrombosis is one of the most common complications in cancer patients. It poses a life-threatening risk and may delay treatment. Because thrombosis is relatively rare in prostate cancer, its occurrence is often underestimated. This review systematizes current data (2010–2025) on the epidemiology, pathogenesis, and management of thrombotic complications in prostate cancer patients. A search was conducted in PubMed, Scopus, and Web of Science using the keywords рак предстательной железы (prostate cancer), венозная тромбоэмболия (venous thromboembolism), андроген-депривационная терапия (androgen-deprivation therapy), AДТ (ADT), гиперкоагуляция (hypercoagulation), онкологический тромбоз (cancer-associated thrombosis), and профилактика (prevention) for 2010–2025. Original studies, systematic reviews, and clinical guidelines were selected. The adjusted thrombosis risk in prostate cancer patients is increased 1.5-fold, with the highest risk in the first 6 months after diagnosis, persisting for 5 years. Pathogenesis involves tissue factor, proinflammatory cytokines, endothelial dysfunction, and thrombocytosis. Standard coagulation tests and thromboelastography may be used to diagnose cancer-related hypercoagulation. Radical prostatectomy, androgen deprivation therapy, chemotherapy, and radiotherapy increase thrombosis risk. Thrombosis may have prognostic value, reflecting tumor aggressiveness, and can cause treatment interruptions and death. Prevention strategies should include risk stratification, pharmacological prophylaxis (low-molecular-weight heparins and oral anticoagulants), and non-pharmacological measures (adequate hydration, physical activity). Thromboembolic complications should be treated for at least 6 months. Prostate cancer carries a significant venous thromboembolism risk, requiring clinician awareness and active screening. Future research should focus on developing validated risk stratification tools specifically for prostate cancer and exploring novel biomarkers and hemostatic monitoring methods.

  • Open Access

    Side effects of androgen deprivation in prostate cancer and their correction: Systematic review

    by L. T. Savin, K. D. Balashova, T. P. Baitman, A. Y. Borukaev, Z. R. Akhmadeev, A. A. Savina, D. M. Monakov, E. Yu. Gritskevich, A. A. Izmailov, A. A. Gritskevich, et al.

    Introduction. Current treatment options for locally advanced and metastatic рrostate cancer offer high survival rates, making quality of life and management of comorbidities, which are often the primary cause of mortality in this cohort, a priority. Metabolic disturbances are one of the most common adverse effects of androgen deprivation therapy. Various treatment options have been described, but no single strategy has been proposed. Aim. To update and systematize modern data on the pathogenesis of metabolic disorders induced by androgen deprivation therapy, and to analyze multidisciplinary approaches to their correction. Materials and methods. A search, analysis, and systematization of relevant publications were conducted in the PubMed, Google Scholar, elibrary.ru, and cyberleninka.ru databases using the following keywords: “prostate cancer” “androgen deprivation therapy”, “metabolic disorders”, “sarcopenia”, “osteoporosis”, and “insulin resistance”. Conference abstracts, dissertation abstracts, and editorial comments were excluded. As a result, 79 of the 158 publications were selected and included in this review. 19 sources were used for the introduction, 60 sources for the main body, and 7 sources, previously mentioned in the main body, for the discussion. Results. Based on this review, we propose recommendations for additional screening of prostate cancer patients receiving androgen-deprivation therapy and present promising approaches to reducing metabolic disturbances and increasing cancer-specific survival. Thus, glucagon-like peptide-1 receptor agonists and statins can not only correct metabolic disorders but also influence carcinogenesis. RANKL inhibitors also have a dual effect, breaking the vicious cycle of bone resorption in metastases. The positive impact of physical activity and nutritional modification on the quality of life and life expectancy of this patient cohort has been demonstrated. Modifications to androgen deprivation therapy through the use of an intermittent regimen or the use of releasing hormone antagonists can also reduce the risk of metabolic complications. Conclusions. An integrated approach to monitoring and treatment improves the quality of life and life expectancy of prostate cancer patients receiving androgen deprivation therapy, as well as the outcomes of systemic antitumor therapy.

  • Open Access

    Perioperative Management Considerations in Nephrectomy with Inferior Vena Cava Thrombectomy in Patients with Renal Cell Carcinoma

    by A. A. Gritskevich, O. V. Strunin, T. P. Baitman, D. A. Parkhomenko, M. B. Shainyan, V. V. Malik, D. M. Monakov, A. Sh. Revishvili

    Renal cell carcinoma is one of the most common oncourological malignancies and is associated with high mortality. Approximately 120,000 new cases of renal cell carcinoma are diagnosed worldwide each year, accounting for nearly 2% of the global cancer incidence. Tumor thrombosis of the inferior vena cava develops in 25-30% of cases and represents a life-threatening condition. According to current clinical guidelines, nephrectomy with thrombectomy is indicated in these patients as a radical surgical procedure or as a cytoreductive procedure within a multimodal treatment strategy. Analysis of surgical outcomes and perioperative management in patients with renal cancer complicated by “high-level” tumor thrombosis of levels III and IV (according to the Mayo Clinic classification) is critically important for improving treatment outcomes in this challenging patient population. The patient’s initial general condition (tumor-related intoxication, anemia, hyperazotemia, venous thrombosis of the lower extremities, along with comorbidities) and the extent of surgical intervention determine a high risk of complications (up to 93%) and in-hospital mortality (up to 10%). Preoperative risk assessment and careful preoperative preparation are essential for the safe surgical intervention and early rehabilitation. Currently, there are no universally accepted management algorithms for patients with tumor thrombosis of the inferior vena cava, and existing recommendations are largely general and do not consider the patient’s clinical condition or the specifics of the surgical intervention. The review aims to integrate current data on the pathophysiological features of the disease, perioperative complications, methods for their prevention and treatment in order to develop individualized approaches to patient management.

  • Viscosipathy: the role in male infertility

    by Yu.V. Olefir, A. R. Zhivulko, D. M. Monakov, A. A. Gritskevich, A. G. Kochetov

    Introduction. Viscosipathy is a violation of the process of dilution of sperm, it is considered one of the possible causes of male infertility. Views on the causes of this condition and its pathogenesis are contradictory. The purpose of this review was to systematize publications on this issue. Materials and methods. As a result of searching for relevant publications in PubMed databases and eLibrary.ru according to the following keywords «male infertility», «viscosipathy», «pathogenesis», «diagnosis», «treatment», 31 publications were selected and included in this review. Results and discussion. Seminal plasma plays an essential role in ensuring normal sperm motility and their protection. The study of sperm viscosity is a mandatory element of its analysis. One of the key etiological factors in the development of viscosipathy is inflammation of the accessory sex glands, which leads to a violation of their function and an increase in the level of oxidative stress. Changes in the content of trace elements and proteolytic fermets in the spermatic plasma are another reason for the development of viscosipathy. This condition can worsen fertility due to impaired sperm motility. Treatment of viscosipathy includes medications that contribute to the resolution of the inflammatory process in the accessory sex glands, as well as enzyme therapy.Conclusions. Viscosipathy is one of the possible causes of male infertility, which can be diagnosed based on a spermogram. The main reason for its occurrence is a violation of the function of the accessory sex glands, most often due to inflammation. Due to the current lack of unified views on the etiology and pathogenesis of this condition, further research in this direction is needed.

  • Open Access

    The anesthetic management and the specific features of perioperative management in cases of nephrectomy with thrombectomy from the inferior vena cava in patients with renal cell cancer

    by Oleg V. Strunin, Tatiana P. Baitman, Maximilyan B. Shainyan, Vasilii V. Malik, Daniil A. Parkhomenko, Dmitry Mikhailivich Monakov, Alexander A. Gritskevich, Amiran Sh. Revishvili, Байтман Татьяна Павловна, Шаинян Максимильян Борисович, et al.

    Renal cell cancer is one of the most widespread oncourological diseases (90% of all the malignant neoplasms in the kidneys) with high mortality. Every year worldwide, approximately 120,000 new cases of renal cell cancer are diagnosed, which is approximately 2% within the structure of the cancer incidence rates, and 65% of the patients are being diagnosed in the developed countries. Nephrectomy is the main method of radical therapy for such patients. In cases of tumor thrombosis of the inferior vena cava, which develops in 25–30% of the cases of renal cell cancer and represents a lethal complication of this disease due to the fragmentation of the thrombotic masses and developing pulmonary embolism, nephrectomy with thrombectomy is indicated. A special category includes the patients with renal cell cancer, complicated by the tumor thrombosis of the inferior vena cava with grades III (thrombus located at the level or above the hepatic veins, but below the diaphragm) and IV (thrombus spreading into the supradiaphragmatic inferior vena cava or into the right atrium) according to the classification by the Mayo Clinic, in which the surgical strategy is accompanied by significantly traumatic manipulations with the liver, the suprahepatic segment of the inferior vena cava, as well as with the heart chambers, suggesting the parallel cardiosurgical intervention. Surgical interventions with this background are accompanied by the complete or the parallel methods of extracorporeal circulation. The initially burdened status of the patient (tumor-related intoxication, anemia, hyperazotemia, in a number of cases thrombosis of the venous system in the lower limbs along with the concomitant abnormalities) and the extent of surgical intervention determine the high risk of complications (up to 93%) and hospital mortality (up to 10%). The preoperative evaluation of the risks of surgery, defining the most favorable tactics for the patient and the thorough preoperative preparation are necessary for the safest course of surgery and for the early rehabilitation of the patient. Currently, there is no unified commonly accepted algorithm adopted for managing such patients, while the developed commonly available standards often have a generalized type, not reflecting the specific features found in the patients with tumor thrombosis of the inferior vena cava. This review attempts to compile the specific features of the anesthetic management in cases of nephrectomy with thrombectomy in patients with renal cell cancer, to describe the main pathophysiological features of the tumor thrombosis of the inferior vena cava, the complications of the perioperative period, the methods for their prevention and treatment. The main directions were provided for the combined diagnostics and treatment, special attention was paid to the multi-disciplinary (urologists, oncologists, cardiovascular and cardiosurgery specialists, anesthesiologists and intensivists) team-based approach to perioperative management of the patients with tumor thrombosis of the inferior vena cava.

  • Late urinary toxicity following radiation in prostate cancer: literature review

    by D. M. Monakov, M. Yu. Kukosh, O. M. Zimovets, A. A. Gritskevich, A. B. Bogdanov, M. D. Ter-Ovanesov

       Introduction. Radiation damage to the bladder is one of the most common complications of radiation therapy for pelvic malignancies.   Materials and methods. The search, analysis and systematization of relevant publications in databases were carried out. e.Library.ru, cyberleninka.ru, PubMed. 64 articles were selected, which are included in this review.   Results and discussion. Data on epidemiology, risk factors, pathogenesis, prevention, diagnosis, and treatment of radiation damage to the bladder are presented.   Conclusions. Hyperbaric oxygenation, intravesical instillation of glycosaminoglycan acid and chondroitin sulfate, as well as transurethral fulguration remain the most effective methods of treating radiation damage to the bladder.

  • Open Access

    Ureteral stents encrustation in patients with oncological diseases.

    by the Department of Urology and Surgical Nephrology of the RUDN University of Russia, A.A. Rakhmatov, Russia Moscow, D.M. Monakov, A.A. Gritskevich, T.P. Baitman, A.A. Kostin

    Introduction. The ureteral stent placement is one of the most common medical procedures in urology. Some patients (for example, after reconstructive surgeries on the upper urinary tract or ones with obstructive uropathy due to pathological processes in the pelvis or retroperitoneal space) require ureteral stents for a long time, which increases the risk of their encrustation. The purpose of this review is to systematize publications on the problem of stent encrustation and to discover for new research directions in this field. Materials and methods. The search, analysis and systematization of relevant publications using keywords in elibrary.ru, PubMed, cyberleninka.ru databases. Conference abstracts, dissertations and their abstracts, as well as editorial comments were excluded. As a result, 62 publications were selected, which were included in this review. Results. Changes in the chemical composition of urine and its pH, protein adsorption and biofilm formation, as well as salt crystallization on the surface of stents are the main pathogenetic mechanisms of inlay. A certain role belongs to the stent’s material, its coating, as well as the duration of its stay in the urinary tract. The diagnosis of stent encrustation is based on the use of ultrasound and X-ray diagnostic methods, mainly computed tomography. As measures to prevent stent encrustation, the possibility of using various materials for their manufacture, the use of medicines and physical factors are under investigation now. Nevertheless, by far the most reliable method of preventing ureteral stent encrustation remains their timely replacement. Conclusion. Encrustation of ureteral stents remains one of the urgent problems of urology. It requires multidisciplinary cooperation between stent manufacturers and medical specialists who deal with such patients in the course of their rutine practice. Prevention of stent encrustation is based on the integrated application of organizational, technical and medical measure.

  • Open Access

    The role of male accessory glands infection and leukospermia in andrological practice.

    by Sh.SH. Ibragimov, Russia Moscow, A.R. Zhivulko, Russia Center For Immunology And Reproduction Llc; Moscow, D.M. Monakov, A.A. Gritskevich, Y.V. Olefir, A.A. Kostin

    Introduction. The inflammatory process in the accessory male sex glands is considered as one of the factors of reducing male fertility, however, the pathogenetic mechanisms of the development of generative dysfunction in this pathology remain poorly understood. Materials and methods. The search, analysis and synthesis of relevant publications in PubMed databases was carried out, eLibrary.ru, cyberleninka.ru by keywords. As a result, 38 publications were selected, which are included in this review. Rusults. Leukospermia is detected in 10-20% of infertile men. An increase in the concentration of leukocytes in the ejaculate in response to the introduction of a bacterial infection is a marker of the inflammatory process developing in the accessory sex glands. An increase in the production of free radicals by activated leukocytes contributes to the development of oxidative stress, one of the main mechanisms of the development of male infertility. Their pathogenetic significance requires further study. It is not clear whether leukospermia and infections of the accessory sex glands have an impact on the results of assisted reproductive technologies (ART). Conclusion. Inflammation of the accessory sex glands can affect male fertility by increasing the concentration of free radicals in the ejaculate. These pathogenetic mechanisms require further study in relation to clinical practice.